AAAAAA
Results: 1-25/31
Authors:
BOSSAVY JP
SAKARIASSEN KS
BARRET A
BONEU B
CADROY Y
Citation: Jp. Bossavy et al., A NEW METHOD FOR QUANTIFYING PLATELET DEPOSITION IN FLOWING NATIVE BLOOD IN AN EX-VIVO MODEL OF HUMAN THROMBOGENESIS, Thrombosis and haemostasis, 79(1), 1998, pp. 162-168
Authors:
CADROY Y
DUPOUY D
BONEU B
Citation: Y. Cadroy et al., ARACHIDONIC-ACID ENHANCES THE TISSUE FACTOR EXPRESSION OF MONONUCLEAR-CELLS BY THE CYCLO-OXYGENASE-1 PATHWAY - BENEFICIAL EFFECT OF N-3 FATTY-ACIDS, The Journal of immunology, 160(12), 1998, pp. 6145-6150
Authors:
CADROY Y
DUPOUY D
BONEU B
PLAISANCE H
Citation: Y. Cadroy et al., POLYMORPHONUCLEAR LEUKOCYTES (PMN) EXERT OPPOSITE REGULATORY EFFECTS ON TISSUE FACTOR (TF) PRODUCTION BY MONOCYTES (M) - ROLE OF REACTIVE OXYGEN SPECIES (ROS), Circulation, 98(17), 1998, pp. 586-586
Authors:
BOSSAVY JP
THALAMAS C
SAGNARD L
BARRET A
SAKARIASSEN K
BONEU B
CADROY Y
Citation: Jp. Bossavy et al., A DOUBLE-BLIND RANDOMIZED COMPARISON OF COMBINED ASPIRIN AND TICLOPIDINE THERAPY VERSUS ASPIRIN OR TICLOPIDINE ALONE ON EXPERIMENTAL ARTERIAL THROMBOGENESIS IN HUMANS, Blood, 92(5), 1998, pp. 1518-1525
Authors:
CADROY Y
DIQUELOU A
DUPOUY D
BOSSAVY J
SAKARIASSEN K
SIE P
BONEU B
Citation: Y. Cadroy et al., THE THROMBOMODULIN PROTEIN-C PROTEIN-S ANTICOAGULANT PATHWAY MODULATES THE THROMBOGENIC PROPERTIES OF THE NORMAL RESTING AND STIMULATED ENDOTHELIUM, Arteriosclerosis, thrombosis, and vascular biology, 17(3), 1997, pp. 520-527
Authors:
BOSSAVY JP
SAKARIASSEN KS
BARRET A
BONEU B
CADROY Y
Citation: Jp. Bossavy et al., EFFECT OF HEPARIN ON ARTERIAL THROMBUS FORMATION USING A NEW METHOD FOR QUANTIFYING PLATELETS IN THROMBI FORMED IN FLOWING NATIVE HUMAN BLOOD, Thrombosis and haemostasis, 1997, pp. 466-466
Authors:
CADROY Y
DUPOUY D
BONEU B
Citation: Y. Cadroy et al., ARACHIDONIC-ACID (AA) ENHANCES THE TISSUE FACTOR (TF) EXPRESSION OF MONONUCLEAR-CELLS (MC) BY THE CYCLOXYGENASE-1 (COX-1) PATHWAY - BENEFICIAL EFFECT OF N-3 FATTY-ACIDS (FA), Thrombosis and haemostasis, 1997, pp. 810-810
Authors:
BOSSAVY JP
THALAMAS C
SAGNARD L
BARRET A
SAKARIASSEN K
BONEU B
CADROY Y
Citation: Jp. Bossavy et al., A DOUBLE-BLIND RANDOMIZED COMPARISON OF COMBINED TICLOPIDINE AND ASPIRINE THERAPY VS TICLOPIDINE OR ASPIRINE ALONE ON EXPERIMENTAL ARTERIALTHROMBOGENESIS IN MAN, Circulation, 96(8), 1997, pp. 4045-4045
Authors:
CADROY Y
GASPIN D
DUPOUY D
LORMEAU JC
BONEU B
SIE P
Citation: Y. Cadroy et al., HEPARIN REVERSES THE PROCOAGULANT PROPERTIES OF STIMULATED ENDOTHELIAL-CELLS, Thrombosis and haemostasis, 75(1), 1996, pp. 190-195
Authors:
SAILLER L
ECOIFFIER M
CADROY Y
COURET B
SIE P
MAZURIER C
ARLETSUAU E
POURRAT JP
Citation: L. Sailler et al., ACQUIRED VON WILLEBRANDS DISEASE-ASSOCIAT ED WITH A MONOCLONAL GAMMOPATHY AND ANGIODYSPLASIA OF THE GUT - A RARE INDICATION TO HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN, La Revue de medecine interne, 17(11), 1996, pp. 929-932
Authors:
ALBUCHER JF
GUIRAUDCHAUMEIL B
CHOLLET F
CADROY Y
SIE P
Citation: Jf. Albucher et al., FREQUENCY OF RESISTANCE TO ACTIVATED PROTEIN-C DUE TO FACTOR-V MUTATION IN YOUNG-PATIENTS WITH ISCHEMIC STROKE, Stroke, 27(4), 1996, pp. 766-766
Authors:
ALBUCHER JF
CADROY Y
SIE P
GUIRAUDCHAUMEIL B
CHOLLET F
Citation: Jf. Albucher et al., RESISTANCE TO ACTIVATED PROTEIN-C IN YOUNG-PATIENTS WITH ISCHEMIC STROKE, Neurology, 46(2), 1996, pp. 6106-6106
Authors:
RAVANAT C
FREUND M
DOL F
CADROY Y
ROUSSI J
INCARDONA F
MAFFRAND JP
BONEU B
DROUET L
LEGRAND C
HERBERT JM
CAZENAVE JP
Citation: C. Ravanat et al., CROSS-REACTIVITY OF HUMAN MOLECULAR MARKERS FOR DETECTION OF PRETHROMBOTIC STATES IN VARIOUS ANIMAL SPECIES, Blood coagulation & fibrinolysis, 6(5), 1995, pp. 446-455
Authors:
DIQUELOU A
DUPOUY D
CARIOU R
SAKARIASSEN KS
BONEU B
CADROY Y
Citation: A. Diquelou et al., A COMPARATIVE-STUDY OF THE ANTICOAGULANT AND ANTITHROMBOTIC EFFECTS OF UNFRACTIONATED HEPARIN AND A LOW-MOLECULAR-WEIGHT HEPARIN (FRAXIPARINE(R)) IN AN EXPERIMENTAL-MODEL OF HUMAN VENOUS THROMBOSIS, Thrombosis and haemostasis, 74(5), 1995, pp. 1286-1292
Authors:
DIQUELOU A
DUPOUY D
GASPIN D
CONSTANS J
SIE P
BONEU B
SAKARIASSEN KS
CADROY Y
Citation: A. Diquelou et al., RELATIONSHIP BETWEEN ENDOTHELIAL TISSUE FACTOR AND THROMBOGENESIS UNDER BLOOD-FLOW CONDITIONS, Thrombosis and haemostasis, 74(2), 1995, pp. 778-783
Authors:
DIQUELOU A
DUPOUY D
SIE P
SAKARIASSEN KS
BONEAU B
CADROY Y
Citation: A. Diquelou et al., SUPPRESSION OF THROMBOMODULIN EXPRESSION ENHANCES THE THROMBOGENICITYOF IL1-STIMULATED ENDOTHELIAL-CELLS AT VENOUS AND ARTERIAL-WALL SHEARRATES, Thrombosis and haemostasis, 73(6), 1995, pp. 899-899
Authors:
CADROY Y
GASPIN D
DUPOUY D
LORMEAU JC
BONEU B
SIE P
Citation: Y. Cadroy et al., ANTICOAGULANT AND NON-ANTICOAGULANT HEPARINS REVERSE THE PROCOAGULANTPROPERTIES OF STIMULATED ENDOTHELIAL-CELLS, Thrombosis and haemostasis, 73(6), 1995, pp. 963-963
Authors:
CADROY Y
SIE P
ALHENCGELAS M
AIACH M
Citation: Y. Cadroy et al., EVALUATION OF APC RESISTANCE IN THE PLASMA OF PATIENTS WITH Q506 MUTATION OF FACTOR-V (FACTOR-V LEIDEN) AND TREATED BY ORAL ANTICOAGULANTS, Thrombosis and haemostasis, 73(4), 1995, pp. 734-735
Authors:
CADROY Y
Citation: Y. Cadroy, EVOLUTION OF ANTIBODIES ANTI-PF4 HEPARIN IN A PATIENT WITH A HISTORY OF HEPARIN-INDUCED THROMBOCYTOPENIA REEXPOSED TO HEPARIN, Thrombosis and haemostasis, 72(5), 1994, pp. 783-784
Authors:
SIE P
CADROY Y
ELIAS A
BOCCALON H
BONEU B
Citation: P. Sie et al., D-DIMER LEVELS IN PATIENTS WITH LONG-TERM ANTECEDENTS OF DEEP VENOUS THROMBOSIS, Thrombosis and haemostasis, 72(1), 1994, pp. 161-162
Authors:
ALGAZI M
ANCELLEPARK R
ASJO B
BARIN F
BARME M
BARRESINOUSSI F
BAYLON H
BENICHOU J
BENICHOU G
BEZEAUD A
BLANCHER A
BLATTNER WA
BLOT P
BOURROUILLOU G
BOUTTIER D
BOVEN B
BRUNET JB
CADROY Y
CAEN J
CAHAN C
CALVAS P
CARANOBE C
CARRELL RW
CHANZY M
CHAOUAT G
CHIODI F
COLOMBIES P
COUTINHO A
DAUSSET J
DEVINCENTI I
DEBRE P
DENIS F
DESMYTER J
DEUBEL V
DEVERGIE A
DODIN A
DORE JF
DREYFUS JC
DREYFUSBRISAC C
DUCOS J
DURAND H
FENYO EM
FLEURY H
FOURNEL JJ
FROTTIER J
GAILLARD J
GALANAUD P
GARCON P
GAZZOLO L
GEORGES AJ
GEORGESCOURBOT MC
GIRARD M
GLUCKMAN E
GLUCKMAN JC
GOLDBERG M
GOUBAU P
GUILLIN MC
HERRAULT A
JENNINGS M
JUHANVAGUE I
KANKI PJ
KAZATCHKINE M
KIRN A
KLATZMANN D
KOHEN JP
KREIS H
KRUH J
LEMINOR L
LESOURD G
LIDEREAU R
LORTHOLARY P
LOWENSTEIN W
LOYGUE J
MARCOVICH H
MARTY M
MATHIOT C
MONODBROCA P
ORTH G
DASILVA LP
PERES G
PILLOT J
POLICARD C
REYNES J
ROZENBAUM W
SCARLATTI G
SCHAISON G
SCHUPBACH J
SIE P
SMILOVICI W
SOURNIA JC
TARANTOLA D
TAVITIAN A
TEDGUI A
TESTAS P
TIOLLAIS P
ULLMAN A
WOLLMAN E
WOLLMAN A
Citation: M. Algazi et al., APPEAL TO MITTERRAND IN BLOOD SCANDAL, Nature, 367(6461), 1994, pp. 312-312
Authors:
DIQUELOU A
LEMOZY S
DUPOUY D
BONEU B
SAKARIASSEN K
CADROY Y
Citation: A. Diquelou et al., EFFECT OF BLOOD-FLOW ON THROMBIN GENERATION IS DEPENDENT ON THE NATURE OF THE THROMBOGENIC SURFACE, Blood, 84(7), 1994, pp. 2206-2213
Authors:
CADROY Y
SIE P
BONEU B
Citation: Y. Cadroy et al., FREQUENCY OF A DEFECTIVE RESPONSE TO ACTIVATED PROTEIN-C IN PATIENTS WITH A HISTORY OF VENOUS THROMBOSIS, Blood, 83(7), 1994, pp. 2008-2009
Authors:
CADROY Y
HANSON SR
KELLY AB
MARZEC UM
EVATT BL
KUNICKI TJ
MONTGOMERY RR
HARKER LA
Citation: Y. Cadroy et al., RELATIVE ANTITHROMBOTIC EFFECTS OF MONOCLONAL-ANTIBODIES TARGETING DIFFERENT PLATELET GLYCOPROTEIN-ADHESIVE MOLECULE INTERACTIONS IN NONHUMAN-PRIMATES, Blood, 83(11), 1994, pp. 3218-3224
Authors:
CADROY Y
HANSON SR
HARKER LA
Citation: Y. Cadroy et al., DERMATAN SULFATE INHIBITION OF FIBRIN-RICH THROMBUS FORMATION IN NONHUMAN-PRIMATES, Arteriosclerosis and thrombosis, 13(8), 1993, pp. 1213-1217